From: Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months
Vitamin D group*___________________________________________ | Placebo group___________________________________________ | |||||
---|---|---|---|---|---|---|
Baseline average expression (dCp) | 12 months average expression (dCp) | aAverage difference in expression (ddCp) | Baseline average expression (dCp) | 12 months average expression (dCp) | aAverage difference in expression (ddCp) | |
let-7f | 0.14 (−0.06, 0.39) | 0.29 (−0.10, 0.45) | 0.11 (−0.38, 0.37) | 0.10 (−0.05, 0.30) | 0.11 (−0.12, 0.29) | −0.12 (−0.34, 0.22) |
let-7a | 1.09 (0.86, 1.18) | 1.06 (0.88, 1.27) | 0.07 (−0.15, 0.26) | 0.94 (0.82, 1.17) | 1.02 (0.81, 1.19) | 0.06 (−0.23, 0.23) |
miR-151-5p | −0.88 (−1.12, -0.68) | −0.90 (−1.08, -0.66) | 0.04 (−0.26, 0.24) | −0.92 (−1.24, -0.76) | −1.14 (−1.35, -0.78) | −0.12 (−0.47, 0.17) |
miR-22 | −0.81 (−1.13, -0.57) | −0.91 (−1.17, -0.56) | −0.09 (−0.38, 0.29) | −0.72 (−1.12, -0.49) | −0.79 (−0.97, -0.48) | −0.04 (−0.19, 0.25) |
miR-221 | 0.03 (−0.32, 0.29) | 0.09 (−0.21, 0.27) | 0.13 (−0.21, 0.29) | 0.02 (−0.27, 0.26) | −0.28 (−0.58, 0.10) | −0.32 (−0.53, 0.10) |
miR-26a | 2.07 (1.90, 2.24) | 2.09 (1.81, 2.25) | −0.02 (−0.29, 0.26) | 1.94 (1.70, 2.11) | 1.83 (1.53, 2.15) | −0.05 (−0.39, 0.25) |
miR-28-5p | −4.10 (−4.51, -3.66) | −4.11 (−4.48, -3.71) | 0.09 (−0.60, 0.53) | −4.14 (−4.63, -3.93) | −4.30 (−4.55, -3.95) | −0.14 (−0.76, 0.32) |
miR-532-3p | −4.80 (−5.05, -4.37) | −4.68 (−4.84, -4.25) | 0.06 (−0.46, 0.63) | −4.66 (−5,21, 4.24) | −4.63 (−5.03, -4.27) | 0.19 (−0.45, 0.42) |
miR-766 | −3.53 (−3.97, -3.30) | −3.59 (−4.01, -3.32) | −0.11 (−0.39, 0.39) | −3.68 (−4.00, -3.41) | −3.72 (−4.14, -3.44) | −0.10 (−0.39, 0.18) |
miR-99b | −3.42 (−3.61, -3.12) | −3.34 (−3.73, -3.04) | 0.03 (−0.42, 0.27) | −3.43 (−3.75, -3.14) | −3.42 (−3.91, -3.23) | 0.04 (−0.33, 0.20) |